GiT Updates and More

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guidelin

Four functional changes are desirable as outcomes for MASH therapy: ✅Anti-inflammatory ✅Metabolic ✅Anti-fibrotic ✅Calorie intake reducing

Pancreatic cysts can be grouped into different types: 1️⃣ Pseudocysts 2️⃣ Common cystic neoplasms: IPMN, SCN, and MCN 3️⃣ Uncommon cystic neoplasms: SPEN 4️⃣ Tumors with cystic degeneration: adenocarcinoma and neuroendocrine tumor

Action of THRβ, PPARα and glucagon agonists on hepatocytes in metabolic dysfunction associated steatohepatitis ( MASH)

Flowchart showing classification and subclassification of steatotic liver disease.

Algorithm for Diagnosis and Management of Esophageal Dysmotility Disorders